Literature DB >> 16931586

Fluorescence in situ hybridization analysis of immunoglobulin heavy chain translocations in plasma cell myeloma using intact paraffin sections and simultaneous CD138 immunofluorescence.

James R Cook1, Marybeth Hartke, James Pettay, Raymond R Tubbs.   

Abstract

Fluorescence in situ hybridization (FISH) studies are much more sensitive than classical cytogenetics for identification of karyotypic abnormalities in plasma cell myeloma. However, FISH analysis of bone marrow samples is often challenging because of a large number of admixed non-neoplastic hematopoietic elements. In this report, we describe a novel method using FISH analysis of intact paraffin sections of formalin-fixed, bone marrow clot preparations with simultaneous CD138 tyramine signal amplification (TSA)-mediated immunofluorescence. We studied 22 cases of plasma cell myeloma for translocations involving the immunoglobulin heavy chain locus that are of known diagnostic and/or prognostic significance. All cases were analyzed using dual color, break-apart immunoglobulin heavy chain probe and dual color, dual fusion probes for t(11;14)(q13;q32) and t(4;14)(p16;q32). TSA-mediated fluorochrome deposition in CD138+ cells was unaltered by protease pretreatment. Translocations were identified in 10 cases, including five with t(11;14)(q13;q32) and three with t(4;14)(p16.3;q32). When present, abnormalities were identified in a large percentage of CD138+ cells (47 to 93%, median 84%). This technique allows for efficient molecular cytogenetic analysis of plasma cell myeloma using routinely archived paraffin-embedded material.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16931586      PMCID: PMC1867625          DOI: 10.2353/jmoldx.2006.050149

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  35 in total

1.  CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma.

Authors:  Nelly Robillard; Herve Avet-Loiseau; Richard Garand; Philippe Moreau; Danielle Pineau; Marie-Josee Rapp; Jean-Luc Harousseau; Regis Bataille
Journal:  Blood       Date:  2003-04-17       Impact factor: 22.113

2.  t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma.

Authors:  R Garand; H Avet-Loiseau; F Accard; P Moreau; J L Harousseau; R Bataille
Journal:  Leukemia       Date:  2003-10       Impact factor: 11.528

Review 3.  Molecular cytogenetic aspects of hematological malignancies: clinical implications.

Authors:  Zhong Chen; Avery A Sandberg
Journal:  Am J Med Genet       Date:  2002-10-30

4.  Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation.

Authors:  Hervé Avet-Loiseau; Thierry Facon; Bernard Grosbois; Florence Magrangeas; Marie-José Rapp; Jean-Luc Harousseau; Stéphane Minvielle; Régis Bataille
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

5.  Multicolor-FICTION: expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses.

Authors:  José Ignacio Martín-Subero; Ilse Chudoba; Lana Harder; Stefan Gesk; Werner Grote; Francisco Javier Novo; María José Calasanz; Reiner Siebert
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

6.  Clinical and biologic implications of recurrent genomic aberrations in myeloma.

Authors:  Rafael Fonseca; Emily Blood; Montserrat Rue; David Harrington; Martin M Oken; Robert A Kyle; Gordon W Dewald; Brian Van Ness; Scott A Van Wier; Kimberly J Henderson; Richard J Bailey; Philip R Greipp
Journal:  Blood       Date:  2003-02-06       Impact factor: 22.113

7.  Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases.

Authors:  Nicole Véronique Smadja; Dominique Leroux; Jean Soulier; Sylvie Dumont; Catherine Arnould; Sylvie Taviaux; Jean Louis Taillemite; Christian Bastard
Journal:  Genes Chromosomes Cancer       Date:  2003-11       Impact factor: 5.006

8.  Simultaneous detection of the immunophenotypic markers and genetic aberrations on routinely processed paraffin sections of lymphoma samples by means of the FICTION technique.

Authors:  A Martínez-Ramírez; J C Cigudosa; L Maestre; S Rodríguez-Perales; E Haralambieva; J Benítez; G Roncador
Journal:  Leukemia       Date:  2004-02       Impact factor: 11.528

9.  The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma.

Authors:  Rafael Fonseca; Carina S Debes-Marun; Elisa B Picken; Gordon W Dewald; Sandra C Bryant; Jerry M Winkler; Emily Blood; Martin M Oken; Rafael Santana-Dávila; Natalia González-Paz; Robert A Kyle; Morie A Gertz; Angela Dispenzieri; Martha Q Lacy; Philip R Greipp
Journal:  Blood       Date:  2003-06-12       Impact factor: 22.113

10.  Genetics and cytogenetics of multiple myeloma: a workshop report.

Authors:  Rafael Fonseca; Bart Barlogie; Regis Bataille; Christian Bastard; P Leif Bergsagel; Marta Chesi; Faith E Davies; Johannes Drach; Philip R Greipp; Ilan R Kirsch; W Michael Kuehl; Jesus M Hernandez; Stephane Minvielle; Linda M Pilarski; John D Shaughnessy; A Keith Stewart; Herve Avet-Loiseau
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 12.701

View more
  7 in total

1.  Successful application of a direct detection slide-based sequential phenotype/genotype assay using archived bone marrow smears and paraffin embedded tissue sections.

Authors:  Victoria Bedell; Stephen J Forman; Karl Gaal; Vinod Pullarkat; Lawrence M Weiss; Marilyn L Slovak
Journal:  J Mol Diagn       Date:  2007-11       Impact factor: 5.568

2.  In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior.

Authors:  Alejandra Carvajal-Cuenca; Luz F Sua; Nhora M Silva; Stefania Pittaluga; Cristina Royo; Joo Y Song; Rachel L Sargent; Blanca Espinet; Fina Climent; Samuel A Jacobs; Jan Delabie; Kikkeri N Naresh; Adam Bagg; Pierre Brousset; Roger A Warnke; Sergi Serrano; Nancy Lee Harris; Steven H Swerdlow; Elaine S Jaffe; Elías Campo
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

3.  Additional-structural-chromosomal aberrations are associated with inferior clinical outcome in patients with hyperdiploid multiple myeloma: a single-institution experience.

Authors:  Adrian A Carballo-Zarate; L Jeffrey Medeiros; Lianghua Fang; Jatin J Shah; Donna M Weber; Sheeba K Thomas; Elisabet E Manasanch; Suyang Hao; Qi Shen; Robert Z Orlowski; Pei Lin; Xinyan Lu
Journal:  Mod Pathol       Date:  2017-03-10       Impact factor: 7.842

4.  Recurrence of posterior polymorphous corneal dystrophy is caused by the overgrowth of the original diseased host endothelium.

Authors:  Stanislava Merjava; Eva Malinova; Petra Liskova; Martin Filipec; Zuzana Zemanova; Kyra Michalova; Katerina Jirsova
Journal:  Histochem Cell Biol       Date:  2011-06-22       Impact factor: 4.304

5.  Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells.

Authors:  Martin Schmidt-Hieber; María Laura Gutiérrez; Martin Pérez-Andrés; Bruno Paiva; Ana Rasillo; Maria Dolores Tabernero; José Maria Sayagués; Antonio Lopez; Paloma Bárcena; María Luz Sanchez; Norma C Gutiérrez; Jesus F San Miguel; Alberto Orfao
Journal:  Haematologica       Date:  2012-08-28       Impact factor: 9.941

6.  Detection of genetic alterations by immunoFISH analysis of whole cells extracted from routine biopsy material.

Authors:  Göran Mattsson; Soo Yong Tan; David J P Ferguson; Wendy Erber; Susan H Turner; Teresa Marafioti; David Y Mason
Journal:  J Mol Diagn       Date:  2007-08-09       Impact factor: 5.568

7.  11C-acetate positron emission tomography is more precise than 18F-fluorodeoxyglucose positron emission tomography in evaluating tumor burden and predicting disease risk of multiple myeloma.

Authors:  Miao Chen; Wenjia Zhu; Jianhua Du; Chen Yang; Bing Han; Daobin Zhou; Li Huo; Junling Zhuang
Journal:  Sci Rep       Date:  2021-11-12       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.